Skip to main content

Table 2 Presentation of characteristics (age, sex, localization) of IBD patients at diagnosis and the frequency of suggestive imaging findings, overall and in ulcerative colitis and Crohn’s disease separately

From: Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study

 

Total number of IBD patients

Patients with Ulcerative colitis

Patients with Crohn’s disease

Severity at diagnosis of IBD

 

According to MAYO score

48% (166/346) Mild

29% (100/346) Moderate

23% (80/346) Severe

According to CDAI score

27% (69/256) Mild

41% (105/256) Moderate

32% (82/256) Severe

Localization

 

24% (83/346) Proctitis

41% (142/346) Left sided colitis

35% (121/346) Pancolitis

29% (74/256) Ileitis

38% (97/256) Colitis

33% (85/256) Ileitis and colitis

Age at diagnosis

39 (Std. Dev. 17.4)

42 (Std. Dev. 18.9)

35 (Std. Dev. 16.3)

Sex (Male/Female)

360 (60%)/ 242 (40%)

202 (58%) /144 (42%)

162 (63%) /94 (37%)

Fatty liver

44 (20%, 44/220)

28

(26.2%, 28/107)

16

(14.2%, 16/113)

Hemangioma

11 (5%, 11/220)

7

(6.5%, 7/107)

4

(3.5%, 4/113)

Cyst

14 (6.3%, 14/220)

8

(7.5%, 8/107)

6

(5.3%, 6/113)

Multiple liver abscesses

1 (0.4%, 1/220)

0

(0%)

1

(0.9%, 1/113)

Fibrosis

1 (0.4%, 1/220)

0

(0%)

1

(0.9%, 1/113)

Cirrhosis

1 (0.4%, 1/220)

0

(0%)

1

(0.9% 1/113)

Portal vein thrombosis

1 (0.4%, 1/220)

1

(0.9%, 1/107)

0

(0%)

Cholelithiasis

32 (14.5%, 32/220)

12

(11.2%, 12/107)

20

(17.7%, 20/113)

Primary sclerosing cholangitis

7 (3.2%, 7/220)

2

(1.9%, 2/107)

5

(4.4%, 5/113)

Cholecystitis

7 (3.2%, 7/220)

3

(2.8%, 3/107)

4

(3.5%, 4/113)

Polyps in the gallbladder

5 (2.3%, 5/220)

4

(3.7%, 4/107)

1

(0.9%, 1/113)

Cholangiocarcinoma

1 (0.4%, 1/220)

1

(0.9%, 1/107)

0

(0%)

Acute pancreatitis

4 (1.8%, 4/220)

0

(0%)

4

(3.5%, 4/113)

Fatty pancreas

2 (0.9%, 2/220)

1

(0.9%, 1/107)

0

(0%)

Chronic pancreatitis

1 (0.4%, 1/220)

1

(0.9%, 1/107)

0

(0%)